GK

Ghanshyam Kumar Kesan

Director Director DIN 09777175
DIN 09777175 First appointment Oct 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Oct 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Ghanshyam Kumar Kesan

Data last updated:

Ghanshyam Kumar Kesan has 3 years in corporate governance. Formerly with 1 company, such as Imedix Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 09777175
Primary Designation Director
First Appointment 31 Oct 2022
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Imedix Healthcare Private Limited U24290WB2022PTC257944
Director31 Oct 20222022₹8.4 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Imedix Healthcare Private Limited
Premium access

Shareholding and investment profile for Ghanshyam Kumar Kesan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ghanshyam Kumar Kesan

Ghanshyam Kumar Kesan has 3 years in corporate governance. Formerly with 1 company, such as Imedix Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

Ghanshyam Kumar Kesan has expertise in Healthcare.

Ghanshyam Kumar Kesan has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available